The present invention relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.
The present disclosure relates generally to compounds and compositions, intermediates, processes for their preparation, and their use as kinase inhibitors.
本公开内容一般涉及化合物和组合物、中间体、其制备工艺及其作为激酶抑制剂的用途。
Verfahren zur Herstellung von 2-Halogenpyridinaldehyden